BlackRock Fund Advisors - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 87 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2016$15,775,000
-13.8%
1,714,727
+10.5%
0.00%
-25.0%
Q3 2016$18,301,000
-4.4%
1,552,250
+5.0%
0.00%0.0%
Q2 2016$19,135,000
-20.2%
1,478,755
-1.3%
0.00%
-33.3%
Q1 2016$23,967,000
-40.9%
1,498,868
+5.9%
0.01%
-33.3%
Q4 2015$40,535,000
-10.2%
1,415,828
-10.7%
0.01%
-25.0%
Q3 2015$45,118,000
-15.4%
1,585,310
+6.7%
0.01%
-7.7%
Q2 2015$53,353,000
+28.0%
1,485,339
+107.1%
0.01%
+30.0%
Q1 2015$41,691,000
+42.3%
717,195
+3.2%
0.01%
+42.9%
Q4 2014$29,305,000
+14.5%
695,087
+5.3%
0.01%0.0%
Q3 2014$25,601,000
+26.1%
660,160
+1.5%
0.01%
+16.7%
Q2 2014$20,310,000
-18.9%
650,326
+7.6%
0.01%
-14.3%
Q1 2014$25,046,000
+67.8%
604,540
+56.8%
0.01%
+40.0%
Q4 2013$14,923,000
+194.2%
385,516
+166.0%
0.01%
+150.0%
Q3 2013$5,072,000
+190.3%
144,942
+14.9%
0.00%
+100.0%
Q2 2013$1,747,000126,1950.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q4 2013
NameSharesValueWeighting ↓
Orbimed Advisors 6,171,440$54,802,0000.52%
Regal Investment Advisors LLC 161,600$1,435,0000.34%
Folger Hill Asset Management LP 396,315$3,519,0000.30%
SCHNEIDER CAPITAL MANAGEMENT CORP 181,900$1,615,0000.29%
Mirae Asset Global Investments Co., Ltd. 1,033,683$9,179,0000.17%
JW Asset Management, LLC 29,409$72,0000.05%
TCI Wealth Advisors, Inc. 9,516$85,0000.04%
GAM Holding AG 83,940$745,0000.03%
Freedom Investment Management, Inc. 63,032$560,0000.03%
Sterling Investment Advisors, Ltd. 5,000$44,0000.03%
View complete list of INSYS THERAPEUTICS INC NEW shareholders